1. Introduction
===============

Benign prostatic hyperplasia (BPH) relates to the nonmalignant growth of the prostate, commonly seen in the elderly male population. The many definitional complications related to BPH lead to further problems with calculations, source of incidence and prevalence rates. Despite many previous researches, the etiology of BPH is still not clearly understood ([@b1-epj-09-5349]). BPH is also a potential cause for physical compression of the urethra that results in anatomic bladder outlet obstruction ([@b2-epj-09-5349]). The symptoms of benign prostatic hyperplasia are generally referred to as "lower urinary tract symptoms" or LUTS ([@b3-epj-09-5349]), and are classified as storage, voiding, and symptoms occurring after urination ([@b4-epj-09-5349]). Voiding symptoms are comprised of intermittency, dribbling, straining, hesitancy, and a decrease in caliber of urine stream ([@b5-epj-09-5349]). Storage symptoms are comprised of the urge to urinate frequently, waking up to urinate throughout the night, feeling of urgency, involuntary urination which includes involuntary urination during sleep, or urge incontinence ([@b6-epj-09-5349]). Analytical epidemiological research has been carried out in order to evaluate risk factors involving the development of benign prostatic hyperplasia. The risk factors associated with BPH are put into two general categories: modifiable (diet, obesity, sex steroid hormones, the metabolic syndrome, diabetes, inflammation, and physical activity) and non-modifiable (age, genetics and geography) ([@b7-epj-09-5349]). Diagnosis of benign prostatic hyperplasia is attained from patients' medical history and a digital per rectal examination ([@b8-epj-09-5349]). Incidence of benign prostatic hyperplasia is relatively common in men and onset of symptoms can be as early as age thirty. By age fifty, up to 50% of men show histologic evidence of BPH symptoms which usually increases with age ([@b1-epj-09-5349]). Prevalence of histologically diagnosed prostatic hyperplasia increases from 8 % in 31 to 40-year-old men, to 40 -- 50 % in 51 to 60-year-old men, and to over 80 % in men older than 80 years ([@b9-epj-09-5349]). Observational studies from the US, Europe and Asia have established that older age is a risk factor for BPH onset and clinical progression by a number of different metrics ([@b10-epj-09-5349]--[@b16-epj-09-5349]). This study was conducted to show the prevalence and determinants of clinically diagnosed prostatic enlargement among elderly men in Arar, Northern Saudi Arabia.

2. Material and Methods
=======================

A cross-sectional study was carried out in Arar city, Northern Saudi Arabia, KSA. This study was conducted during the period from February 2017 to July 30, 2017, on all consented elderly males (more than 60 years old) attending the outpatient clinic of the urology department of Arar Central Hospital. Each participant underwent a general examination and digital per rectal to detect general chronic diseases, obesity and prostatic enlargement. A pre-designed questionnaire was used for data collection. Data was collected from 81 elderly males aged from 60 to +90 years old. The pre designed questionnaire included questions designed to fulfill the study objectives. The questionnaire consisted of questions and checklists about socio-demographic characteristics (age, educational level, marital status and occupational status), and questions about chronic diseases, body mass index (BMI) and smoking status, and presence of senile enlarged prostate (SEP) and prostatic tumors. All the data were analyzed by SPSS version 16 (SPSS Inc., Chicago, Illinois, USA) through descriptive statistics and Chi-squared test. P-value of less than 0.05 was considered statistically significant. Permission to conduct the study was obtained from the Research and Ethics Committee at the College of Medicine, Northern Border University, Arar, Saudi Arabia. The questionnaire had a brief introduction explaining the aims and significance of the study.

3. Results
==========

[Table 1](#t1-epj-09-5349){ref-type="table"} illustrates socio-demographic characteristics of the cases, chronic diseases and BMI status of the studied elderly population. In total, 29.6% of the studied cases were aged less than 60, 35.8% between (60--70), 27.2% between (70--80) and only 7.4% more than 90 years old (mean age was 70±9.25). Of these, 90.1% were married, 28.4% were highly educated, and 56.8% of them were retired.

Regarding chronic diseases and BMI status; 37% of the cases had hypertension, 29.6% had DM and 13.6% had IHD. Mean BMI (± SD) was 29.99±9.73. Only 18.5% of the cases were smokers. Our findings showed that 16 participants (19.8%) had senile prostatic enlargement and three participants (3.7%) had prostatic tumors; while 62 participants (76.5%) had normal prostate. [Table 2](#t2-epj-09-5349){ref-type="table"} illustrates the relationship between sociodemographic characteristics, smoking history, presence of DM and obesity and presence of SPE among the studied elderly population. There was significant relation between SPE and age as 6.2% of cases were 60--69 years, 43.8% were 70--79 years and 44.0% were 80 years or more (p\<0.05). There was also significant relation between SPE and obesity as 10 (62.5%) of the cases were obese and 6 (37.5%) were non-obese (p\<0.05). There was no significant relation with marital status, smoking or diabetes (p\<0.05).

4. Discussion and conclusions
=============================

Senile prostatic enlargement is one of the most common diseases among the elderly. It is a common problem that affects the quality of life in approximately one third of men older than 50 years ([@b17-epj-09-5349]). Our study was conducted to estimate the prevalence and determinants of the clinically diagnosed senile prostatic enlargement in Arar, Northern Saudi Arabia. In the current study, there was significant relation between SPE and age (p\<0.05). A recent study by Alghamidi et al. in 2013 ([@b18-epj-09-5349]) showed that the incidence is higher than expected, with an age-standardized incidence rate of up to 10.1 in the eastern region. One further study by Al-Abdin et al. ([@b19-epj-09-5349]) investigated the detection rate of prostate cancer in a cohort of Saudi men compared to their Canadian counterparts; it was evident from their report that there was a significantly low detection rate of prostate cancer in the Saudi group even with PSA values as high as 10 ng/mL, which suggested an increase in the threshold for taking a TRUS-guided biopsy. This was in line to the results of a study conducted on men aged between 55 to74, which reported 19% as prevalence of prostatic enlargement ([@b13-epj-09-5349]). Through autopsy studies, a histological prevalence of 8%, 50% and 80% in the 4th, 6th and 9th decades of life, respectively, has been observed ([@b20-epj-09-5349]). In West African men ([@b21-epj-09-5349]), the prevalence of prostate enlargement was 62.3%, which was much higher than our figure. Also, the figures from our study are less than the figures stated for predominantly white populations in the United States 36.3 and 42.0% ([@b22-epj-09-5349], [@b23-epj-09-5349]). In the present study, there was no association between senile prostatic enlargement and diabetes mellitus (43.8% in diabetics vs. 56.2% in non-diabetics). Physician-diagnosed diabetes, increased serum insulin and elevated fasting plasma glucose however, have been associated with increased prostate size and an increased risk of prostate enlargement, clinical BPH and BPH surgery in a number of varied cohort studies on tens of thousands of men ([@b24-epj-09-5349]--[@b27-epj-09-5349]). In the present study, there was association between senile prostatic enlargement and obesity (62.5% in obese vs. 37.5% in non obese). Previous studies have reported that increased adiposity is positively associated with prostate volume: The greater the amount of adiposity, the greater the prostate volume. Body mass index has been positively associated with prostate volume in a number of varied study populations ([@b24-epj-09-5349]). Prostate enlargement in obese participants (BMI ≥ 35 kg/m^2^) had an increased risk of 3.5-fold, compared with non-obese (BMI \<25 kg/m^2^) participants ([@b28-epj-09-5349]). In summary, our study showed that senile prostatic enlargement is one of the significant important issues in public health in Arar city, Northern Saudi Arabia. The prevalence of this condition reaches 19.3%, thereby placing even greater burden on the quality of life of the elderly and on the health system. While age plays a role in the development of the condition, obesity as a modifiable variable contributes as well. So, we recommend health education sessions to inform the elderly population on how to control their body weight. The availability of drug therapy makes it appropriate for the primary care providers to participate in the management of men with this disorder.
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###### 

Socio-demographic characteristics, chronic diseases and BMI status of the studied elderly population, Arar, 2016

  Variables              n            \%     
  ---------------------- ------------ ------ ------
  Age (years); 70±9.25   \<60         24     29.6
  60--70                 29           35.8   
  \>70                   28           34.6   
  Marital status         Widow        3      3.7
  Single                 3            3.7    
  Married                73           90.1   
  Divorced               2            2.5    
  Educational level      Illiterate   22     27.2
  Primary                17           21.0   
  Preparatory            9            11.1   
  Secondary              10           12.3   
  University or more     23           28.4   
  Working status         Shepherd     15     18.5
  No work                20           24.7   
  Retired                46           56.8   
  Chronic diseases       DM           24     29.6
  Hypertension           30           37.0   
  IHD                    11           13.6   
  Smoking                Non-smoker   44     54.3
  Smokers                15           18.5   
  Ex-smokers             22           27.2   

###### 

Relationship between sociodemographic characteristics, smoking history, presence of DM and prostate gland status among the studied elderly population, Arar, 2017

  Variable            Senile Prostatic enlargement; n (%)   Total (n=81); n (%)   p-value                 
  ------------------- ------------------------------------- --------------------- ----------- ----------- -------
  Age group (years)   \<60                                  1 (6.2)               23 (35.4)   24 (29.6)   0.016
  60--70              7 (43.8)                              22 (33.8)             29 (35.8)               
  \>70                8 (44.0)                              20 (30.8)             28(34.6)                
  Marital status      Widow                                 1 (6.2)               2 (3.1)     3 (3.7)     0.170
  Single              0 (0.0)                               3 (4.6)               3 (3.7)                 
  Married             14 (87.5)                             59 (90.8)             73 (90.1)               
  Divorced            1 (6.2)                               1 (1.5)               2 (2.5)                 
  Smoking history     Non-smoker                            8 (50.0)              36 (55.4)   44 (54.3)   0.204
  Smokers             3 (18.8)                              12 (18.4)             15 (18.5)               
  Ex-smoker           5 (31.2)                              17 (26.1)             22 (27.2)               
  Diabetes mellitus   Yes                                   7 (43.8)              17 (26.1)   24 (29.6)   0.316
  No                  9 (56.2)                              48 (73.8)             57 (70.4)               
  Obesity             Yes                                   10 (62.5)             11 (16.9)   21 (25.9)   0.041
  No                  6 (37.5)                              54 (83.1)             60 (74.1)               
